The Global CEO Initiative on Alzheimer's Disease
Acronym: CEOi
General Information
Identification Code: 320304848476-75
Website: [object Object]
Entity Form: Network of organizations affiliated with UsAgainstAlzheimer's (501c3)
Registration Category: Non-governmental organisations, platforms and networks and similar
Registration Date: 12/22/2022
Last Update: 12/22/2023
EP Accredited Number: 0
Mission & Interests
Goals: The Global CEO Initiative on Alzheimer’s Disease (CEOi), founded in 2013, is an organization of private-sector leaders who have joined together to provide business leadership in the fight against Alzheimer’s. The CEOi believes that, during this era of aging populations, it will take visionary, coordinated, goal-oriented leadership of public and private leaders working together to solve our greatest challenges. It is convened by UsAgainstAlzheimer’s. Members consist of public and private healthcare organizations invested in healthy aging, brain health, and Alzhiemer's Disease research, policy and advocacy.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Banking and financial services
- Business and industry
- Communication
- Consumers
- Education and training
- Employment and social affairs
- External relations
- International co-operation and development
- Public health
- Regional policy
- Research and innovation
- Trans-European Networks
Levels of Interest:
- national
- global
- european
- sub-national
Activities
Main EU Legislative Proposals: Institute for Healthcare Imprvement
Healtheir Together - EU NCD Initiative
EU4Health
Horizon Europe
EU Cohesion POlicy
NextGenerationEU: Recovery and Resilience Facility
European Green Deal
European Digital Strategy
Pharmaceutical Strategy for Europe
Communication Activities: • We have developed and published thought pieces on accelerated approval in US and how this informs strategies in Europe as it relates to Alzheimer's and brain health.
• Support and engage in Alzheimer's and brain health advocacy activities across Europe including partnership with World Economic Forum, OECED, Alzheimer's International and European Brain Council
• Convene global Alzheimer's research and policy conference, Lausanne Workshop. This is convened by Alzheimer's Disease International, OECD, and the World Economic Forum. To identify unmet solutions in brain health, aging, and Alzheimer's research and care.
• Ongoing collaboration with the World Health Organization on their dementia policy plan
Host round table series on areas of research and innovation in brain health and Alzheimer's with speakers from industry, policy, and advocacy organizations.
Inter-institutional or Unofficial Groupings: Social economy,Competitive European Industry: long-term and sustainable investment,Demographic challenges, family-work balance and youth transition,Disability,SME
Head Office
Address: The Global CEO Initiative on Alzheimer's Disease
Post Code: 20043
City: Washington, DC
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: 155 East Lancaster Ave
Post Code: 19087
City: Wayne
Country: UNITED STATES
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: N/A
Membership Information
Members10 Percent: 0
Members25 Percent: 2
Members50 Percent: 4
Members75 Percent: 2
Members: 10
Members F T E: 6
Info Members: A total of 10 individuals involved in the organization.
Structure
Structure Type: Structure
Is Member Of: AARP https://www.aarp.org/
Janssen: https://www.janssen.com/
Eli Lilly: https://www.lilly.com/
AbbVie: https://www.abbvie.com/
Bank of America: https://www.bankofamerica.com/
Roche: https://www.roche.com/
Prothena: https://www.prothena.com/
World Health Organization: https://www.who.int/
AC Immune: https://www.acimmune.com/
World Economic Forum: https://www.weforum.org/?_gl=1*16m65do*_up*MQ..&gclid=CjwKCAiAnZCdBhBmEiwA8nDQxcHAGAsn36ShZkmup-bkBmgxeEzSN8av6Y5iNmkRp-Qr4FFlDqy40hoCq0wQAvD_BwE
Global Alzheimer's Platform Foundation: https://globalalzplatform.org/
UnitedHealthcare: https://www.uhc.com/
Otsuka: https://www.otsuka-us.com/
Neurovision: https://neurovision.com/
Anavex: https://www.anavex.com/
OECD: https://www.oecd.org/unitedstates/
Biogen: https://www.biogen.com/home.html
Home Instead: https://www.homeinstead.com/ppc/dual/home-instead-senior-care/
Alzheimer's Disease International: https://www.alzint.org/
Optum Labs: https://www.optumlabs.com/
Eisai: https://www.eisai.com/index.html
Cerecin: https://www.cerecin.com/
Cognito Therapeutics: https://cognitotx.com/
Merck: https://www.merck.com/
C2N: https://c2n.com/
Altoida: https://altoida.com/
K2 Medical Research: https://k2med.com/
Progressive Medical Research: https://www.progressivemedicalresearch.com/
Organisation Members: UsAgainstAlzheimer's: https://www.usagainstalzheimers.org/